Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas

Cancer Research

Volumn 64, Issue 15, 2004, Pages 5048-5050

  Broderick, Daniel K ^a   Di, Chunhui ^a   Parrett, Timothy J ^a   Samuels, Yardena R ^b   Cummins, Jordan M ^b   McLendon, Roger E ^a   Fults, Daniel W ^c   Velculescu, Victor E ^b   Bigner, Darell D ^a   Yan, Hai ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3 KINASE;

ADVANCED CANCER; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; BREAST CANCER; CANCER GRADING; CHILDHOOD CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVE SITE; ENZYME SUBUNIT; GENE CLUSTER; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG CANCER; MEDULLOBLASTOMA; OLIGODENDROGLIOMA; ONCOGENE; PIK3CA GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PTEN GENE; STOMACH CANCER; TARGET CELL; TUMOR SUPPRESSOR GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ASTROCYTOMA; BRAIN NEOPLASMS; DNA, NEOPLASM; HUMANS; MEDULLOBLASTOMA; MUTATION; OLIGODENDROGLIOMA; PHOSPHORIC MONOESTER HYDROLASES;

EID: 3442878125     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1170     Document Type: Article

References (17)

1. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
2. Cantley LC. The phosphoinositide 3-kinase pathway. Science (Wash DC) 2002;296:1655-7.
3. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Wash DC) 1997;275:1943-7.
4. Fults D, Pedone CA, Thompson GE, et al. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Int J Oncol 1998;12:905-10.
5. Choe G, Horvath S, Cloughesy TF, et al. Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 2003;63:2742-6.
6. Shayesteh L, Lu Y, Kuo WL, et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999;21:99-102.
7. Ma YY, Wei SJ, Lin YC, et al. PIK3CA as an oncogene in cervical cancer. Oncogene 2000;19:2739-44.
8. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Investig 2001;81:717-23.
9. Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science (Wash DC) 2004;304:554.
10. Wang TL, Rago C, Silliman N, et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci USA 2002;99:3076-80.
11. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999;1:44-51.
12. Rasheed BK, Wiltshire RN, Bigner SH, Bigner DD. Molecular pathogenesis of malignant gliomas. Curr Opin Oncol 1999;11:162-7.
13. Tohma Y, Gratas C, Biernat W, et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 1998;57:684-9.
14. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000;59:333-7.
15. Wechsler-Reya RJ. Analysis of gene expression in the normal and malignant cere-bellum. Recent Prog Horm Res 2003;58:227-48.
16. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003;62:111-26.
17. Smith JS, Jenkins RB. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 2000;5:D213-31.